Kalaris Therapeutics, Inc.

KLRS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 20 employees
107
SEC Filings
$2.66
Close 2026-10-06
20
Employees

Business Summary

Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing TH103, a novel anti-VEGF fusion protein (VEGF trap) engineered for extended intraocular retention and enhanced VEGF inhibition in retinal diseases. TH103 uses extracellular domains D2 and D3 of native VEGFR1 fused to IgG1 Fc. The company is targeting neovascular age-related macular degeneration (nAMD) with plans to expand into diabetic eye disease and retinal vein occlusion.

Latest Stock Quote

KLRS 2026-10-06 $2.66 O:$2.9 H:$2.93 L:$2.61 Vol:0.1M VWAP:$2.7776
origin leaf: null

Next Earnings

expected 2026-11-10

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-172025-12-310001193125-26-110659EDGAR126K words
2025-03-072024-12-310000950170-25-035143EDGAR120K words
2024-03-152023-12-310000950170-24-031879EDGAR106K words
2023-02-152022-12-310000950170-23-002830EDGAR108K words
2022-02-102021-12-310000950170-22-001075EDGAR111K words
2021-02-122020-12-310001564590-21-005652EDGAR112K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-112026-06-300001193125-26-344532EDGAR82K words
2025-11-122025-09-300001193125-25-277464EDGAR85K words
2025-08-132025-06-300000950170-25-107979EDGAR81K words
2025-05-142025-03-310000950170-25-071339EDGAR84K words
2024-11-122024-09-300000950170-24-125295EDGAR65K words
2024-08-092024-06-300000950170-24-094380EDGAR63K words
2024-05-132024-03-310000950170-24-058607EDGAR61K words
2023-11-022023-09-300000950170-23-058145EDGAR58K words
2023-08-032023-06-300000950170-23-037926EDGAR58K words
2023-05-042023-03-310000950170-23-017814EDGAR55K words
2022-11-032022-09-300000950170-22-021829EDGAR64K words
2022-08-042022-06-300000950170-22-014726EDGAR63K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-110001193125-26-343477EDGAR2K words
2026-07-200001193125-26-308382EDGAR8K words
2026-07-170001193125-26-306737EDGAR6K words
2026-03-170001193125-26-109437EDGAR2K words
2026-03-090001193125-26-097548EDGAR6K words
2025-12-180001193125-25-323706EDGAR1K words
2025-12-170001193125-25-322950EDGAR4K words
2025-11-120001193125-25-276060EDGAR2K words
2025-11-030001193125-25-261697EDGAR7K words
2025-08-130001193125-25-179466EDGAR1K words

107 total filings indexed. 79 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

neovascular-age-related-macular-degeneration-(namd) diabetic-macular-edema-(dme) diabetic-retinopathy-(dr) retinal-vein-occlusion-(rvo) exudative-and-neovascular-retinal-diseases intravitreal-injection-administration optical-coherence-tomography-(oct)-imaging best-corrected-visual-acuity-(bcva)-measurement central-subfield-thickness-(cst)-measurement

Company Identity

CIK0001754068
TickerKLRS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.kalaristx.com
Listed2025-03-19

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ac77404b72c0b10edfc105af2a79449ab56aeac8ef5212a49591cec6c4a14b96
parent: 2182612875c8e7833edfe46fc51416b1606f1035e85f50c20e7559b7e0ea5b8b
content hash: 327b03fdee7059eb0a66e39cc3384b285a351628dac4f0abbe9d6fe67f7ceaed
signed: 2026-10-13T19:01:59.048Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up KLRS using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on KLRS, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/KLRS (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.